HealthDay on MSN54m
Zepbound Bests Wegovy for Weight Loss in New TrialZepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly. "Given the increased interest around obesity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback